INSIGHTS ON CLINICAL TRIAL PARTNERING

• Top 10 Global Pharma Company Dramatically Improves Site Payments In Drive To Become Sponsor Of Choice

  See how a pharma company reduced investigator payment cycle time by 55% while decreasing their own administrative burden by 90% in this metrics-rich case study.

• Open-Label Study Assessing Relative And Absolute Bioavailability

  Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.

• New Purpose-Built Facility For Large-Scale Sterile Fill/Finish Operations

  Expanding capacity for late-phase clinical and large-scale commercial small molecule and biologic drugs, a new facility boosts sterile fill/finish capabilities.

• The Hidden Cost Of Transactional Burden: It's Time For Sites To Speak Up

  Transactional burdens weigh heavily on sites, straining trust with sponsors and patients. See why site voices matter and how sounding off can strengthen clinical trial relationships.

• Breaking Silos In Drug Development: The Power Of An Integrated Model

  5/11/2026

  Experts share how Altasciences' integrated Preclinical/Clinical model results in fewer handoffs, greater continuity, and accelerated progress from the nonclinical phase to first-in-human trials.

• The Bioanalysis CRO Selection Checklist Every Sponsor Should Use Before Signing An MSA

  3/9/2026

  Choosing a CRO requires more than proposals. Assess reliability, automation, GLP rigor, scientific engagement, pricing clarity, and capacity to find partners who deliver defensible data on real timelines.

• How To Accelerate Early-Phase Oncology Trial

  5/12/2026

  Purpose-built early-phase oncology sites can enroll patients within 7–10 days post-activation while maintaining quality and diversity; academic centers often lag due to complexity and saturation.

• Global e-Consent Matrix

  3/9/2026

  Navigate complex regional regulations and identity requirements to modernize your global clinical trial enrollment. Ensure compliance and access while moving toward digital participant engagement.

• Vendor Selection Bias: Why Structured Decisions Often Fail

  12/22/2025

  Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.